Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks...I got it as a recommendation from a guy I follow.
Wow! Awesome Job and Congratulations!! I love hearing stuff like this!
Good luck man...I didn’t buy options here. I bought for $9.00 a share and just wanted to see if a second bidder showed up.
I'm hoping there is a 2nd ARQL Bidder who is waiting until the last day to show his hand. Otherwise $20 will be the Deal and my calls will expire worthless. Either way this was nothing more than a lotto for me that has some potential on paying off Big if we get a 2nd offer? A month ago the calls were flying off the shelf and this did not look like retail to me. Good Luck to us.
You were right...the bid expires on January 15th at 11:59 pm. We have a few more trading days...
Hoping 2nd bidder emerges by next week as we are running out of time here. If I was the 2nd bidder I would wait until the last minute.
That would be amazing!!!
All I know is that I would love to see AQRL Halted for News and then see our new offer appear. I would be one happy camper! :)
I thought that might be right...I must have accidentally erased the email a couple weeks ago.
Not right off hand? Somebody had said they have until the 15th? Not sure if that is the date or not?
I received an email about selling or I would receive $20 for each share...I can’t find the email though. Do you remember the date we have to sell by?
Maybe if there is a 2nd bidder they are going to wait until the last minute to reveal themselves? They probably do not want to attract any other bidders. I followed the Big Money who bought a ton of calls in December signaling a 2nd ARQL Bidder behind the scenes. We shall see?
Come on 2nd Bidder Reveal yourself now! I would like to see that offer increased to at least $25. Merck is stealing ARQL for just $20.
$ARQL...solid investment in 2019
Ihub and big boards?
Try Twitter and Stocktwits...
I'm surprised with all that is going on with this nobody is on this board other than you and I? Big Board Stock Boards are like Ghost Towns! LOL :) ARQL looking Great today!
I Would love for this to be the week where ARQL gets a 2nd Bidder! Talk about an Amazing Christmas Gift! I have my Fingers, Toes, and everything else crossed here! Go ARQL!!!
I agree, and why I went heavy on the calls. This is crazy buying here!
God I hope you are right about this! :)
I am sure you are following elite...
Good luck
Hedge fund arbitragers perhaps
do it again with APTO
Congrats on the entry point!! That is a sizable gain....I'm in at $6.98.......any thoughts on what you do with your shares moving forward?
Well done and congratulations again!!
$ARQL...been following their trial closely..
DD wins here
Make money
Invest wisely
If you wasn't in before today you missed the pop
$ARQL...I am holding a large position since $4.80. I am not missing a thing here..
Make money
Invest wisely
You are gonna miss lots of profits today , I think , Alas but more trading opportunities are here I think
$ARQL bears and bulls Arqule Inc Nasdaq Arql Short Squeeze
* * $ARQL Video Chart 11-27-2019 * *
Link to Video - click here to watch the technical chart video
* * $ARQL Video Chart 11-19-19 * *
Link to Video - click here to watch the technical chart video
$ARQL...back in early October when I posted that, many thought it was a typo.
Nope, it was not.
$ARQL sold my shares, but watching for another trend reversal
* * $ARQL Video Chart 11-12-19 * *
Link to Video - click here to watch the technical chart video
Ok just trying to get some perspective. Thanks!
$ARQL.....in apparent response to a just-released abstract on blood cancer candidate ARQ 531, a reversible BTK inhibitor, that will be presented at ASH next month.
https://ash.confex.com/ash/2019/webprogram/Paper127260.html
I believe people are comparing this BTK inhibitor Phase ! dosing and safety to Lilly more favorable safety profile
There is more there......for example a lower dose of 65 mg is now being tested and safer...more to follow
Definitely not the only ones, any feel for why its dropping so much? News was pretty good, no insider trades etc.???
$ARQL- is Clay and I the only ones who know about $ARQL?
come on people-make some money!
$ARQL staying above $8.49 and breaking $8.79 is what I expect to see by EOW.
Bullish-enjoy
Followers
|
32
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
369
|
Created
|
07/19/06
|
Type
|
Free
|
Moderators |
http://finance.yahoo.com/q/h?s=ARQL
http://library.corporate-ir.net/library/82/829/82991/items/251342/ArQuleJune07.pdf
http://www.clinicaltrials.gov/ct/search;jsessionid=6800B95BD4EAC4F758634AECE97FE6F8?term=arqule
ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets. Its lead product ARQ 197 is an orally administered inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in microphthalmia transcription factor associated tumors, non-small cell lung cancer, pancreatic adenocarcinoma, and hepatocellular carcinoma. The company?s clinical stage products also include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. It?s preclinical and discovery programs comprise ARQ 621 focused on inhibition of the Eg5 kinesin spindle protein; ARQ 761, a second-generation E2F-1 activator; and BRAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |